Anti-tumor mechanism of evodiamine on gastric cancer cells in vitro through MAPK signaling pathway
Basic Medicine|更新时间:2026-01-09
|
Anti-tumor mechanism of evodiamine on gastric cancer cells in vitro through MAPK signaling pathway
Journal of Third Military Medical UniversityVol. 43, Issue 16, Pages: 1535-1542(2021)
作者机构:
1.712000 陕西 咸阳,陕西中医药大学: 附属医院肿瘤科
2.712000 陕西 咸阳,陕西中医药大学: 药学院
3.712000 陕西 咸阳,陕西中医药大学: 基础医学院
作者简介:
基金信息:
the General Program of National Natural Science Foundation of China(82074255);the Project of Natural Basic Research Plan of Shaanxi Province(2020JQ-859)
Weina QIAN, Zhi LI, Yu FANG, et al. Anti-tumor mechanism of evodiamine on gastric cancer cells in vitro through MAPK signaling pathway[J]. Journal of Third Military Medical University, 2021, 43(16): 1535-1542.
DOI:
Weina QIAN, Zhi LI, Yu FANG, et al. Anti-tumor mechanism of evodiamine on gastric cancer cells in vitro through MAPK signaling pathway[J]. Journal of Third Military Medical University, 2021, 43(16): 1535-1542. DOI: 10.16016/j.1000-5404.202103002.
Anti-tumor mechanism of evodiamine on gastric cancer cells in vitro through MAPK signaling pathway
To investigate the anti-tumor effect of evodiamine on gastric cancer cells
via
the MAPK signaling pathway.
Methods
2
MTT assay was used to assess the cell viability of SGC-7901 cells after the treatment of 8
16 and 32 μmol/L evocarpine (denoted as A
1
group
A
2
group
A
3
group). The effect of p38 inhibitor on the above cells (denoted as B
1
group
B
2
group
B
3
group) were studied. The blank control cell group was the cells treated with culture medium. Annexin V-FITC/PI was used to observe cell apoptosis
PI staining to observe cell cycle
Western blotting to measure apoptosis-related proteins Bcl-2 and cleaved-caspase-3
and scratch healing test to evaluate the inhibitory effect on cell migration. Western blotting was employed to detect the expression levels of c-dc2
cdc25C
cyclin B1
and p-ERK and p-p38.
Results
2
Evodiamine negatively inhibited the proliferation of SGC-7901 cells in a dose-dependent and time-dependent manner. The IC
50
values at 24 and 48 h were 16.78 and 7.28 μmol/L
respectively. Compared with the control group (0.06%)
the apoptotic rate of SGC-7901 cells was increased in groups A
1
A
2
and A
3
(18.72%
31.08% and 52.17%)
and the cells arrested at G
2
/M phase. The proportion of apoptotic cells in group B was decreased
there were less cells arrested at G
2
/M phase
and the expression of G
2
/M phase regulatory proteins CDC2
CDC25C and Cyclin B1 were down-regulated when compared with group A (all
P
<
0.05). The scratch healing test showed that the healing rate of SGC-7901 cells was decreased with the increase of evodiamine concentration. Compared with groups A
1
A
2
and A
3
(59.13%
23.15% and 18.31%)
the rate was increased in groups B
1
B
2
and B
3
(63.17%
55.27%
34.08%
P
<
0.05). Western blot results indicated that evodiamine treatment induced the up-regulation of Bcl-2 and cleaved caspase-3
down-regulation of p-ERK
and obvious elevation of p-p38 (
P
<
0.05). Compared with group A
the expression levels of CDC2
CDC25C and Cyclin B1 were increased
those of Bcl-2 and cleaved caspase-3 were significantly decreased
while that of p-ERK was up-regulated and that of p-p38 was down-regulated in group B (
P
<
0.05).
Conclusion
2
Evodiamine shows anti-tumor effect on gastric cancer cells
and it is realized by the down-regulation of p-p38 protein and up-regulation of apoptosis-related proteins through MAPK signaling pathway.
关键词
Keywords
references
YUSEFI A R, BAGHERI LANKARANI K, BASTANI P, et al . Risk factors for gastric cancer: a systematic review[J ] . Asian Pac J Cancer Prev, 2018, 19(3): 591-603. DOI: 10.22034/APJCP.2018.19.3.591.
CHEN W, ZHENG R, BAADE P D, et al . Cancer statistics in China, 2015[J ] . CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
SONG Z Y, WU Y, YANG J B, et al . Progress in the treatment of advanced gastric cancer[J ] . Tumour Biol, 2017, 39(7): 1010428317714626. DOI: 10.1177/1010428317714626.
PAULA D P, BRASIL COSTA V I, JORGE R V, et al . Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer[J ] . Support Care Cancer, 2020, 28(1): 395-403. DOI: 10.1007/s00520-019-04841-x.
WANG J H, LYU S W, LI M, et al . Anti-breast cancer mechanism of active ingredients of traditional Chinese medicine in vitro[J ] . Chin J Exp Tradit Med Formulae, 2020, 26(17): 197-203. DOI: 10.13422/j.cnki.syfjx.20201725.
LIU L, ZHANG X M, XU J, et al . Chemical components and pharmacological action for Euodiae Fructus and predictive analysis on its Q-marker[J ] . Chin Tradit Herb Drugs, 2020, 51(10): 2689-2702. DOI: 10.7501/j.issn.0253-2670.2020.10.012.
YANG H Q, HOU J P, SUN T. Evodiamine affects cervical cancer HeLa cell proliferation and apoptosis and its mechanism[J]. Chin J Clin Pharmacol, 2020, 36(20): 3298-3301. DOI: 10.13699/j.cnki.1001-6821.2020.20.031.
LIU L, WANG X M, WANG Y, et al . Evodiamine promotes apoptosis of glioma SHG-44 cells and its mechanism[J ] . Acta Acad Med Sin, 2020, 42(5): 591-595. DOI: 10.3881/j.issn.1000-503X.11853.
BRAICU C, BUSE M, BUSUIOC C, et al . A comprehensive review on MAPK: a promising therapeutic target in cancer[J ] . Cancers, 2019, 11(10): 1618. DOI: 10.3390/cancers11101618.
WU H, WANG W, TONG S, et al . Nucleostemin regulates proliferation and migration of gastric cancer and correlates with its malignancy[J ] . Int J Clin Exp Med, 2015, 8(10): 17634-17643.
NEVES FILHO E H, DE SANT'ANA R O, NUNES L V, et al . Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review[J ] . APMIS, 2017, 125(2): 79-84. DOI: 10.1111/apm.12642.
SUN Z Q, WANG Q S, YU X B, et al . Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China[J ] . Int J Clin Exp Med, 2015, 8(11): 21358-21364.
SHITARA K, BANG Y J, IWASA S, et al . Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer[J ] . N Engl J Med, 2020, 382(25): 2419-2430. DOI: 10.1056/NEJMoa2004413.
JIN P, JI X Y, KANG W Z, et al . Artificial intelligence in gastric cancer: a systematic review[J ] . J Cancer Res Clin Oncol, 2020, 146(9): 2339-2350. DOI: 10.1007/s00432-020-03304-9.
YUAN X J, DENG S H. Research progress of traditional Chinese medicine in the treatment of malignant tumors[J]. Lishizhen Med Mater Med Res, 2019, 30(9): 2232-2234.
XIAO Y, DUAN J F, LIU Y, et al . Historic successive changes of euodiae fructus in processing methods and functions[J ] . Chin J Exp Tradit Med Formulae, 2017, 23(3): 223-228. DOI: 10.13422/j.cnki.syfjx.2017030223.
LIU N, LI Y X, CHEN G Z, et al . Evodiamine induces reactive oxygen species-dependent apoptosis and necroptosis in human melanoma A-375 cells[J ] . Oncol Lett, 2020, 20(4): 121. DOI: 10.3892/ol.2020.11983.
GUAN X Y, ZHENG X T, VONG C T, et al . Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro [J ] . Eur J Pharmacol, 2020, 875: 173031. DOI: 10.1016/j.ejphar.2020.173031..
YOU Z, LIU S P, DU J, et al . Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: a review[J ] . J Oral Pathol Med, 2019, 48(3): 201-205. DOI: 10.1111/jop.12807.
DROSTEN M, BARBACID M. Targeting the MAPK pathway in KRAS-driven tumors[J]. Cancer Cell, 2020, 37(4): 543-550. DOI: 10.1016/j.ccell.2020.03.013.
GUO Y J, PAN W W, LIU S B, et al . ERK/MAPK signalling pathway and tumorigenesis[J ] . Exp Ther Med, 2020, 19(3): 1997-2007. DOI: 10.3892/etm.2020.8454.
LOW H B, ZHANG Y. Regulatory roles of MAPK phosphatases in cancer[J]. Immune Netw, 2016, 16(2): 85-98. DOI: 10.4110/in.2016.16.2.85.
PAPA S, CHOY P M, BUBICI C. The ERK and JNK pathways in the regulation of metabolic reprogramming[J]. Oncogene, 2019, 38(13): 2223-2240. DOI: 10.1038/s41388-018-0582-8.
HUANG Y Q, ZOU Y, LIN L H, et al . miR-101 regulates the cell proliferation and apoptosis in diffuse large B-cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway[J ] . Oncol Rep, 2019, 41(1): 377-386. DOI: 10.3892/or.2018.6821.
MARTÍNEZ-LIMÓN A, JOAQUIN M, CABALLERO M, et al . The p38 pathway: from biology to cancer therapy[J ] . Int J Mol Sci, 2020, 21(6): E1913. DOI: 10.3390/ijms21061913.
STRAMUCCI L, PRANTEDA A, BOSSI G. Insights of crosstalk between p53 protein and the MKK 3 /MKK 6 /p38 MAPK signaling pathway in cancer[J ] . Cancers (Basel), 2018, 10(5): E131. DOI: 10.3390/cancers10050131..
WANG J N, ZHANG Z R, CHE Y, et al . Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer[J ] . Cancer Biol Ther, 2018, 19(7): 609-621. DOI: 10.1080/15384047.2018.1449613.
LIU K, ZHENG M Y, LU R, et al . The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review[J ] . Cancer Cell Int, 2020, 20: 213. DOI: 10.1186/s12935-020-01304-w.
Effect and mechanism of H. pylori in regulation of REDD1 expression in gastric mucosa
Tetrandrine sensitizes vincristine to induce apoptosis in SGC-7901/VCR cells through MAPK signaling pathway
Antitumor activity of 2 new evodiamine derivatives against small-cell lung cancer cells in vitro
Evodiamine inhibits migration and invasion of colorectal cancer SW480 cells via suppressing NF-κB-p65 signaling pathway
Molecular mechanism of inhibition of 8-gingerol on proliferation of breast cancer cells
Related Author
Zongbao YAN
Fangyuan MAO
Zhiguo SHAN
Yongliang ZHAO
Yuan ZHUANG
Ling LEI
Xiuxing JIANG
Yan WANG
Related Institution
Department of General Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Microbiology and Biochemical Pharmacy, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)
Department of Pharmacognosy and Traditional Chinese Medicine, Faculty of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University)
Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology
Chongqing Collegiate Pharmaceutical Engineering Research Center, College of Pharmacy, Chongqing Medical University